XML 42 R31.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment Reporting (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting |
Schedule of activity of Company's segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended March 31,
​ | ​ ​ ​ | 2026 | ​ ​ ​ | 2025
​ | ​ | Ophthalmic | ​ | Digital | ​ | Corporate/ | ​ | ​ | ​ | ​ | Ophthalmic | ​ | Digital | ​ | Corporate/ | ​ | ​ | ​
​ | ​ ​ ​ | Technology | ​ ​ ​ | Assets | ​ ​ ​ | Other | ​ ​ ​ | Total | ​ ​ ​ | Technology | ​ ​ ​ | Assets | ​ ​ ​ | Other | ​ ​ ​ | Total
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Revenue: | ​ ​ ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Revenue | ​ | $ | — | ​ | $ | 244,271 | ​ | $ | — | ​ | $ | 244,271 | ​ | $ | 14,720 | ​ | $ | — | ​ | $ | — | ​ | $ | 14,720
Less: | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​
Cost of revenue | ​ |  | — | ​ |  | — | ​ | ​ | — | ​ |  | — | ​ |  | (48) | ​ |  | — | ​ | ​ | — | ​ |  | (48)
Gross Income (Loss) | ​ |  | — | ​ |  | 244,271 | ​ | ​ | — | ​ |  | 244,271 | ​ |  | 14,672 | ​ |  | — | ​ | ​ | — | ​ |  | 14,672
Less: | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​
Research and Development: | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ | ​ | ​ | ​ |  | ​
Salaries and benefits | ​ |  | 123,106 | ​ |  | — | ​ | ​ | — | ​ |  | 123,106 | ​ |  | 420,000 | ​ |  | — | ​ | ​ | — | ​ |  | 420,000
Direct clinical and non-clinical expenses | ​ |  | 60,841 | ​ |  | — | ​ | ​ | — | ​ |  | 60,841 | ​ |  | 72,657 | ​ |  | — | ​ | ​ | — | ​ |  | 72,657
Facilities expenses | ​ |  | 11,788 | ​ |  | — | ​ | ​ | — | ​ |  | 11,788 | ​ |  | 70,837 | ​ |  | — | ​ | ​ | — | ​ |  | 70,837
Non-cash stock based compensation expenses | ​ |  | 38,934 | ​ |  | — | ​ | ​ | — | ​ |  | 38,934 | ​ |  | 64,677 | ​ |  | — | ​ | ​ | — | ​ |  | 64,677
Supplies and materials | ​ |  | — | ​ |  | — | ​ | ​ | — | ​ |  | — | ​ |  | 25,130 | ​ |  | — | ​ | ​ | — | ​ |  | 25,130
Other Expenses(1) | ​ |  | 3,880 | ​ |  | — | ​ | ​ | — | ​ |  | 3,880 | ​ |  | 19,742 | ​ |  | — | ​ | ​ | — | ​ |  | 19,742
Depreciation expense | ​ |  | 48,215 | ​ |  | — | ​ | ​ | — | ​ |  | 48,215 | ​ |  | — | ​ |  | — | ​ | ​ | — | ​ |  | —
Realized gain - digital assets and digital assets receivable | ​ | ​ | — | ​ | ​ | (3,623,764) | ​ | ​ | — | ​ | ​ | (3,623,764) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Unrealized gain - digital assets | ​ |  | — | ​ |  | (10,973,979) | ​ | ​ | — | ​ |  | (10,973,979) | ​ |  | — | ​ |  | — | ​ | ​ | — | ​ |  | —
Unrealized gain – digital intangible assets receivable | ​ | ​ | — | ​ | ​ | (367,251) | ​ | ​ | — | ​ | ​ | (367,251) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Impairment loss - digital intangible assets | ​ |  | — | ​ |  | 1,231,668 | ​ | ​ | — | ​ |  | 1,231,668 | ​ |  | — | ​ |  | — | ​ | ​ | — | ​ |  | —
Net gain (loss) on derivative instruments | ​ | ​ | — | ​ | ​ | (39,401) | ​ | ​ | — | ​ | ​ | (39,401) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Provision for credit losses | ​ | ​ | — | ​ | ​ | 504,511 | ​ | ​ | — | ​ | ​ | 504,511 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Reacquisition of license rights | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | —
Segment (income) loss | ​ | ​ | 286,764 | ​ | ​ | (13,512,487) | ​ | ​ | — | ​ | ​ | (13,225,723) | ​ | ​ | 673,043 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 673,043
Reconciling Items | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Selling, general and administrative expense(2) | ​ |  | — | ​ |  | — | ​ | ​ | 4,493,604 | ​ |  | 4,493,604 | ​ |  | 2,372,322 | ​ |  | — | ​ | ​ | — | ​ |  | 2,372,322
Other (income) expense, net (3) | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (108,431) | ​ | ​ | (108,431) | ​ | ​ | 452,840 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 452,840
Net Income (Loss) | ​ | $ | (286,764) | ​ | $ | 13,512,487 | ​ | $ | (4,385,173) | ​ | $ | 8,840,550 | ​ | $ | (3,483,533) | ​ | $ | — | ​ | $ | — | ​ | $ | (3,483,533)
(1) | Other research and development expenses include outsourced engineering and IT systems used for research and development.
(2) | Selling, general and administrative expenses primarily include professional fees, general and administrative compensation expenses, general strategic consulting, Nasdaq/SEC fees, insurance and facilities expenses.
(3) | Other (income) expense, net includes interest income, interest expense and gain on extinguishment of liabilities.
Schedule of segment assets | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ ​ ​ | March 31, 2026 | ​ ​ ​ | December 31, 2025
​ | ​ | Ophthalmic | ​ | Digital | ​ | Corporate/ | ​ | ​ | ​ | ​ | Ophthalmic | ​ | Digital | ​ | Corporate/ | ​ | ​ | ​
​ | ​ ​ ​ | Technology | ​ ​ ​ | Assets | ​ ​ ​ | Other | ​ ​ ​ | Total | ​ ​ ​ | Technology | ​ ​ ​ | Assets | ​ ​ ​ | Other | ​ ​ ​ | Total
Segment Assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash | ​ | $ | — | ​ | $ | — | ​ | $ | 7,380,922 | ​ | $ | 7,380,922 | ​ | $ | — | ​ | $ | — | ​ | $ | 6,443,467 | ​ | $ | 6,443,467
Digital assets | ​ |  | — | ​ |  | 60,739,409 | ​ |  | — | ​ |  | 60,739,409 | ​ |  | — | ​ |  | 43,872,033 | ​ |  | — | ​ |  | 43,872,033
All other assets | ​ |  | 71,105 | ​ |  | — | ​ |  | 1,874,527 | ​ |  | 1,945,632 | ​ |  | 132,652 | ​ |  | — | ​ |  | 1,316,104 | ​ |  | 1,448,756
Total Assets | ​ | $ | 71,105 | ​ | $ | 60,739,409 | ​ | $ | 9,255,449 | ​ | $ | 70,065,963 | ​ | $ | 132,652 | ​ | $ | 43,872,033 | ​ | $ | 7,759,571 | ​ | $ | 51,764,256
​

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration